These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7275813)

  • 41. Studies on the biosynthesis of carbapenem antibiotics. II. Isolation and functions of a specific acylase involved in the depantothenylation of the OA-6129 compounds.
    Kubo K; Ishikura T; Fukagawa Y
    J Antibiot (Tokyo); 1984 Nov; 37(11):1394-402. PubMed ID: 6511667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity of thienamycin.
    Shah PM
    Methods Find Exp Clin Pharmacol; 1981; 3(6):387-90. PubMed ID: 7329164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Consecutive radical S-adenosylmethionine methylations form the ethyl side chain in thienamycin biosynthesis.
    Marous DR; Lloyd EP; Buller AR; Moshos KA; Grove TL; Blaszczyk AJ; Booker SJ; Townsend CA
    Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10354-8. PubMed ID: 26240322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Four further antibiotics related to olivanic acid produced by Streptomyces olivaceus: fermentation, isolation, characterisation and biosynthetic studies.
    Box SJ; Hood JD; Spear SR
    J Antibiot (Tokyo); 1979 Dec; 32(12):1239-47. PubMed ID: 317283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibiotics produced by mutants of Streptomyces caelestis. II. N-demethylcelesticetin and N-demethyl-7-O-demethylcelesticetin.
    Argoudelis AD; Coats JH; Lemaux PG; Sebek OK
    J Antibiot (Tokyo); 1973 Jan; 26(1):7-14. PubMed ID: 4781281
    [No Abstract]   [Full Text] [Related]  

  • 46. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. II. Structure of 2-hydroxyaklavinone and new aklavinone glycosides.
    Matsuzawa Y; Yoshimoto A; Shibamoto N; Tobe H; Oki T; Naganawa H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Aug; 34(8):959-64. PubMed ID: 7319928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Formal synthesis of Thienamycin.
    Pieczykolan M; Furman B; Chmielewski M
    J Antibiot (Tokyo); 2017 Jun; 70(6):781-787. PubMed ID: 28377636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. I. Isolation and characterization of various blocked mutants.
    Yoshimoto A; Matsuzawa Y; Oki T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Aug; 34(8):951-8. PubMed ID: 6947976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure of a new antibiotic curromycin A produced by a genetically modified strain of Streptomyces hygroscopicus, a polyether antibiotic producing organism.
    Ogura M; Nakayama H; Furihata K; Shimazu A; Seto H; Otake N
    J Antibiot (Tokyo); 1985 May; 38(5):669-73. PubMed ID: 3839499
    [No Abstract]   [Full Text] [Related]  

  • 50. Chlorocardicin, a monocyclic beta-lactam from a Streptomyces sp. II. Isolation, physico-chemical properties and structure determination.
    Chan JA; Shultis EA; Dingerdissen JJ; DeBrosse CW; Roberts GD; Snader KM
    J Antibiot (Tokyo); 1985 Feb; 38(2):139-44. PubMed ID: 3838979
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Giant linear plasmids of beta-lactam antibiotic producing Streptomyces.
    Netolitzky DJ; Wu X; Jensen SE; Roy KL
    FEMS Microbiol Lett; 1995 Aug; 131(1):27-34. PubMed ID: 7557307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ansatrienin A2 and A3: minor components of the ansamycin complex produced by Streptomyces collinus.
    Lazar G; Zähner H; Damberg M; Zeeck A
    J Antibiot (Tokyo); 1983 Feb; 36(2):187-9. PubMed ID: 6833138
    [No Abstract]   [Full Text] [Related]  

  • 53. A stereocontrolled, enantiomerically specific total synthesis of thienamycin.
    Salzmann TN; Ratcliffe RW; Bouffard FA; Christensen BG
    Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):191-5. PubMed ID: 6109315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thienamycin: development of imipenen-cilastatin.
    Kahan FM; Kropp H; Sundelof JG; Birnbaum J
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():1-35. PubMed ID: 6365872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
    Schröter G; Schrettenbrunner A; Strenzel I
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 1-Epidactimicin, a new aminoglycoside antibiotic converted from fortimicin B by a blocked mutant of istamycin-producing Streptomyces tenjimariensis.
    Morioka M; Hotta K; Ikeda D; Naganawa H; Hamada M; Okami Y
    J Antibiot (Tokyo); 1989 May; 42(5):831-3. PubMed ID: 2722692
    [No Abstract]   [Full Text] [Related]  

  • 57. Structures of olivanic acid derivatives MM 22380, MM 22381, MM 22382 and MM 22383; four new antibiotics isolated from Streptomyces olivaceus.
    Brown AG; Corbett DF; Eglington AJ; Howarth TT
    J Antibiot (Tokyo); 1979 Sep; 32(9):961-3. PubMed ID: 511786
    [No Abstract]   [Full Text] [Related]  

  • 58. 8-Deoxylankolide from a lankamycin producing Streptomyces spp.
    Ju J; Goo YM
    J Antibiot (Tokyo); 1997 Aug; 50(8):690-2. PubMed ID: 9315083
    [No Abstract]   [Full Text] [Related]  

  • 59. beta-lactam antibiotic production by Streptomyces clavuligerus mutants impaired in regulation of aspartokinase.
    Mendelovitz S; Aharonowitz Y
    J Gen Microbiol; 1983 Jul; 129(7):2063-9. PubMed ID: 6313854
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structures of OA-6129D and E, new carbapenam antibiotics.
    Yoshioka T; Watanabe A; Kojima I; Shimauchi Y; Okabe M; Fukagawa Y; Ishikura T
    J Antibiot (Tokyo); 1984 Mar; 37(3):211-7. PubMed ID: 6547129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.